ADC Therapeutics SA (ADCT): Form 8-K filed 2026-10-13
- Accepted by EDGAR
- 2026-10-13 06:26 ET
- Event date
- 2026-10-07
- Accession no.
- 0000950103-26-015465
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements. - Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 3.02: Unregistered Sales of Equity Securities
The company sold equity securities in a transaction not registered under the Securities Act, such as a private placement, above a size threshold. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | dp254756_8k.htm |
| EX-10.1 | EXHIBIT 10.1 | dp254756_ex1001.htm |
| EX-10.2 | EXHIBIT 10.2 | dp254756_ex1002.htm |
| EX-10.3 | EXHIBIT 10.3 | dp254756_ex1003.htm |
| EX-10.4 | EXHIBIT 10.4 | dp254756_ex1004.htm |
| EX-10.5 | EXHIBIT 10.5 | dp254756_ex1005.htm |
| EX-99.1 | EXHIBIT 99.1 | dp254756_ex9901.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.